FDA actions support US jobs and medicine security
The article discusses efforts by the U.S. government, under President Trump, to revitalize domestic pharmaceutical manufacturing and reduce dependence on foreign supply chains. The FDA has launched initiatives such as the PreCheck Pilot Program to streamline the approval process for U.S.-based facilities, creating jobs and ensuring a stable supply of medicines, including essential generic drugs. These measures aim to improve supply security, foster economic growth, and safeguard American patients by bringing drug production and clinical research back to the United States.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading